Skip to content
Search

Latest Stories

Government accepts JCVI advice on COVID-19 and flu vaccination programmes

Government accepts JCVI advice on COVID-19 and flu vaccination programmes

The government will continue to provide COVID-19 vaccinations to frontline health and social care staff and care home workers in the autumn 2024 programme

The government has accepted the Joint Committee on Vaccination and Immunisation's (JCVI) advice for the autumn 2024 COVID-19 vaccination programme.


According to the JCVI, the following groups will be eligible for vaccination this autumn:

  • Individuals aged 65 and over
  • Residents of care homes for older adults
  • Those aged 6 months and older in clinical risk groups

Minister for Public Health and Prevention, Andrew Gwynne, emphasised the importance of protecting vulnerable populations from COVID-19 and reducing pressure on the NHS.

He said: “We are committed to protecting those most vulnerable from COVID and have accepted the independent advice from the JCVI for the autumn 2024 vaccination programme.”

“I encourage anyone invited for a vaccine to get one as soon as possible to protect yourself and reduce pressure on the NHS during winter, helping to cut waiting times and get the health service back on its feet.”

Additionally, Gwynne announced that the government will continue to offer COVID-19 vaccinations to frontline NHS and social care workers and staff in care homes for older people this autumn.

The JCVI did not recommend including frontline health and social care workers, staff in care homes for older adults, unpaid carers, and household contacts of immunosuppressed individuals in the national programme.

The JCVI suggested that health and social care service providers consider setting up an occupational health vaccination programme for frontline workers, similar to the existing flu vaccine programme.

However, since implementing a new occupational health programme before autumn 2024 is not feasible, the JCVI recommended that health departments might opt to continue offering vaccinations through the national programme this autumn.

Consequently, the government has decided to maintain the provision of COVID-19 vaccinations to frontline health and social care staff, as well as staff working in care homes for older people, in the autumn 2024 programme.

Earlier, the JCVI advised NHS England to move the start of the flu vaccination programme for most adults to the beginning of October.

This change is based on evidence showing that the flu vaccine’s effectiveness can decrease over time in adults.

The goal is to complete the majority of vaccinations by the end of November, aligning more closely with the start of the flu season.

Bases on this advice, NHS England has confirmed the following start dates for the commencement of the service for pharmacies and general practices:

  • 1st September 2024: Pregnant women
  • 3rd October 2024: All other eligible adult patients

In previous years, flu vaccinations have been offered from September.

The NHS will not cover the cost of vaccinations administered outside these specified dates.

Pharmacy teams should inform their patients about the later start to the programme and the reasons behind NHS England's decision.

Community Pharmacy England has developed a poster to help communicate this information in pharmacies.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less